$1.13
+0.02 (+1.80%)
Open$1.12
Previous Close$1.11
Day High$1.15
Day Low$1.11
52W High$3.28
52W Low$1.18
Volume—
Avg Volume1.77M
Market Cap710.09M
P/E Ratio—
EPS$-1.84
SectorPharmaceuticals
Analyst Ratings
Buy
12 analysts
Price Target
+1,979.6% upside
Current
$1.13
$1.13
Target
$23.50
$23.50
$17.63
$23.50 avg
$33.45
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.57B | 1.95B | 156.52M |
| Net Income | -3,494,607,543 | -3,893,472,132 | 22.40M |
| Profit Margin | -222.4% | -211.2% | 14.3% |
| EBITDA | -632,863,868 | -744,269,218 | 28.04M |
| Free Cash Flow | — | — | 15.05M |
| Rev Growth | -19.2% | -19.2% | +1.7% |
| Debt/Equity | 0.67 | 0.67 | 0.23 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |